pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$CINGCingulate Inc.

$CING
Kansas City, KS, USupdated 16d ago

Cingulata, part of the superorder Xenarthra, is an order of armored New World placental mammals. The armadillos, whose species are split between the families Dasypodidae and Chlamyphoridae, are the only surviving members of the order. Two groups of cingulates much larger than extant armadillos existed until recently: pampatheriids, which reached weights of up to 200 kg (440 lb) and chlamyphorid glyptodonts, which attained masses of 2,000 kg (4,400 lb) or more.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(2)

pipeline depth2 products
Preclinical: 1pre_registration: 1
1Preclinical1pre_registration
Preclinical
dextroamphetamine
Attention Deficit Hyperactivity Disorder (ADHD)
pre_registration
DEXMETHYLPHENIDATE HYDROCHLORIDE
Attention Deficit Hyperactivity Disorder (ADHD)
Sodium-dependent noradrenaline transporterSodium-dependent dopamine transporter

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase3Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.completedn=26
  • phase3Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301completedn=103
  • phase3Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301suspendedn=45
  • phase1In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)completedn=25

Insider activity

source: SEC Form 4
routine RSU / option mechanics (6)
  • Mar 9, 26grantSilva Raul R. · EVP and CSO4,526 sh
  • Mar 9, 26tax coverSilva Raul R. · EVP and CSO1,828 sh
  • Mar 9, 26grantSchaffer Shane J. · Chief Executive Officer6,862 sh
  • Mar 9, 26tax coverSchaffer Shane J. · Chief Executive Officer2,959 sh
  • Mar 9, 26grantCallahan Jennifer L. · EVP and CFO15,329 sh
  • Mar 9, 26tax coverCallahan Jennifer L. · EVP and CFO6,427 sh
🐶 Hiring Signal
No open roles indexed yet — view Cingulate Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$CING
SEC CIK
0001862150
country
US
source
sec_tickers
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?